

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phenol-containing compound biosynthetic process (GO:0046189) | 7.92417207 |
| 2 | melanosome organization (GO:0032438) | 7.63544449 |
| 3 | pigment granule organization (GO:0048753) | 7.30999324 |
| 4 | retinal rod cell development (GO:0046548) | 6.72125142 |
| 5 | developmental pigmentation (GO:0048066) | 6.67657403 |
| 6 | melanocyte differentiation (GO:0030318) | 6.56980718 |
| 7 | pigment cell differentiation (GO:0050931) | 6.40463594 |
| 8 | pigment biosynthetic process (GO:0046148) | 6.25938028 |
| 9 | ketone body metabolic process (GO:1902224) | 5.67315440 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.63053089 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.54314312 |
| 12 | synaptic vesicle maturation (GO:0016188) | 5.47991002 |
| 13 | pigment metabolic process (GO:0042440) | 5.43326790 |
| 14 | locomotory exploration behavior (GO:0035641) | 5.33513899 |
| 15 | inositol phosphate catabolic process (GO:0071545) | 5.26252620 |
| 16 | response to epinephrine (GO:0071871) | 5.14323509 |
| 17 | secondary metabolic process (GO:0019748) | 5.09349030 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.08018256 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 4.97780494 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.91860520 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.90161588 |
| 22 | vocalization behavior (GO:0071625) | 4.85689958 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.80935532 |
| 24 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.76397564 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 4.69387371 |
| 26 | neuroepithelial cell differentiation (GO:0060563) | 4.69146576 |
| 27 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.64825181 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.62841298 |
| 29 | inositol phosphate dephosphorylation (GO:0046855) | 4.58541701 |
| 30 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.58541701 |
| 31 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.57269326 |
| 32 | regulation of DNA endoreduplication (GO:0032875) | 4.47224951 |
| 33 | glutamate secretion (GO:0014047) | 4.46349452 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.45854640 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.41102686 |
| 36 | neuronal action potential propagation (GO:0019227) | 4.38549388 |
| 37 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.36742767 |
| 38 | protein localization to synapse (GO:0035418) | 4.35816360 |
| 39 | polyol catabolic process (GO:0046174) | 4.28794171 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 4.27627657 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.26209993 |
| 42 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.25347275 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.22078240 |
| 44 | melanosome transport (GO:0032402) | 4.19981892 |
| 45 | cellular response to reactive nitrogen species (GO:1902170) | 4.13732686 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.13635393 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.07844156 |
| 48 | synaptic transmission, glutamatergic (GO:0035249) | 4.02270641 |
| 49 | neurotransmitter secretion (GO:0007269) | 3.99500880 |
| 50 | neuron-neuron synaptic transmission (GO:0007270) | 3.98472677 |
| 51 | establishment of melanosome localization (GO:0032401) | 3.98451675 |
| 52 | exploration behavior (GO:0035640) | 3.98223768 |
| 53 | pigment granule transport (GO:0051904) | 3.97849866 |
| 54 | neuron cell-cell adhesion (GO:0007158) | 3.96894108 |
| 55 | regulation of superoxide anion generation (GO:0032928) | 3.95490211 |
| 56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93791262 |
| 57 | prepulse inhibition (GO:0060134) | 3.90593765 |
| 58 | positive regulation of membrane potential (GO:0045838) | 3.89902977 |
| 59 | dendritic spine morphogenesis (GO:0060997) | 3.88793069 |
| 60 | auditory behavior (GO:0031223) | 3.87403098 |
| 61 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.87110642 |
| 62 | regulation of cellular respiration (GO:0043457) | 3.85369616 |
| 63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.83942403 |
| 64 | piRNA metabolic process (GO:0034587) | 3.82013393 |
| 65 | positive regulation of receptor recycling (GO:0001921) | 3.79624191 |
| 66 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.79142702 |
| 67 | establishment of pigment granule localization (GO:0051905) | 3.78218007 |
| 68 | synaptic transmission, dopaminergic (GO:0001963) | 3.75905652 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.74498962 |
| 70 | negative regulation of organelle assembly (GO:1902116) | 3.74335752 |
| 71 | long-term memory (GO:0007616) | 3.74052043 |
| 72 | melanosome localization (GO:0032400) | 3.73731125 |
| 73 | striatum development (GO:0021756) | 3.72220772 |
| 74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.68279886 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 3.66801836 |
| 76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.63119626 |
| 77 | regulation of postsynaptic membrane potential (GO:0060078) | 3.62282793 |
| 78 | negative regulation of interleukin-1 production (GO:0032692) | 3.61504546 |
| 79 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.59724626 |
| 80 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.59174944 |
| 81 | regulation of synaptic plasticity (GO:0048167) | 3.57591661 |
| 82 | pigment granule localization (GO:0051875) | 3.56104973 |
| 83 | transmission of nerve impulse (GO:0019226) | 3.52936021 |
| 84 | behavioral response to cocaine (GO:0048148) | 3.50496927 |
| 85 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.50271975 |
| 86 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.47757009 |
| 87 | long-term synaptic potentiation (GO:0060291) | 3.47295621 |
| 88 | adenosine receptor signaling pathway (GO:0001973) | 3.46793104 |
| 89 | response to auditory stimulus (GO:0010996) | 3.46537299 |
| 90 | layer formation in cerebral cortex (GO:0021819) | 3.46127655 |
| 91 | pigmentation (GO:0043473) | 3.45318816 |
| 92 | negative regulation of neurological system process (GO:0031645) | 3.44746328 |
| 93 | activation of protein kinase A activity (GO:0034199) | 3.44035831 |
| 94 | neuromuscular process controlling balance (GO:0050885) | 3.42313366 |
| 95 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.41535467 |
| 96 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.40256505 |
| 97 | gamma-aminobutyric acid transport (GO:0015812) | 3.40023058 |
| 98 | signal peptide processing (GO:0006465) | 3.39967629 |
| 99 | negative regulation of TOR signaling (GO:0032007) | 3.39310114 |
| 100 | presynaptic membrane assembly (GO:0097105) | 3.36165370 |
| 101 | cullin deneddylation (GO:0010388) | 3.36104647 |
| 102 | proteasome assembly (GO:0043248) | 3.36093999 |
| 103 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.35862257 |
| 104 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.35862257 |
| 105 | neuronal ion channel clustering (GO:0045161) | 3.35364370 |
| 106 | dopamine transport (GO:0015872) | 3.32475169 |
| 107 | regulation of neurotransmitter secretion (GO:0046928) | 3.29507604 |
| 108 | negative regulation of acute inflammatory response (GO:0002674) | 3.26354564 |
| 109 | negative regulation of JUN kinase activity (GO:0043508) | 3.26085020 |
| 110 | response to amphetamine (GO:0001975) | 3.25500851 |
| 111 | positive regulation of response to oxidative stress (GO:1902884) | 3.24409337 |
| 112 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.24409337 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.23635244 |
| 114 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.22452593 |
| 115 | regulation of female receptivity (GO:0045924) | 3.20779680 |
| 116 | neurotransmitter transport (GO:0006836) | 3.20459052 |
| 117 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.19989798 |
| 118 | regulation of neurotransmitter transport (GO:0051588) | 3.19247533 |
| 119 | presynaptic membrane organization (GO:0097090) | 3.18631534 |
| 120 | postsynaptic membrane organization (GO:0001941) | 3.18129191 |
| 121 | membrane hyperpolarization (GO:0060081) | 3.16960988 |
| 122 | mechanosensory behavior (GO:0007638) | 3.16395832 |
| 123 | dopamine receptor signaling pathway (GO:0007212) | 3.15236371 |
| 124 | regulation of glutamate secretion (GO:0014048) | 3.14941719 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.14243910 |
| 126 | cAMP catabolic process (GO:0006198) | 3.13679491 |
| 127 | positive regulation of protein autophosphorylation (GO:0031954) | 3.13568896 |
| 128 | regulation of vesicle fusion (GO:0031338) | 3.12928861 |
| 129 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.12511335 |
| 130 | membrane depolarization (GO:0051899) | 3.10106428 |
| 131 | regulation of dendritic spine development (GO:0060998) | 3.09541183 |
| 132 | detection of calcium ion (GO:0005513) | 3.08603828 |
| 133 | response to muscle activity (GO:0014850) | 3.07760105 |
| 134 | synapsis (GO:0007129) | 3.07756498 |
| 135 | dendritic spine organization (GO:0097061) | 3.07215350 |
| 136 | flavonoid metabolic process (GO:0009812) | 3.07043119 |
| 137 | neuron recognition (GO:0008038) | 3.03094346 |
| 138 | learning (GO:0007612) | 3.03040817 |
| 139 | positive regulation of synaptic transmission (GO:0050806) | 3.02316464 |
| 140 | glycine transport (GO:0015816) | 3.02166745 |
| 141 | visual learning (GO:0008542) | 3.02131056 |
| 142 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.01023240 |
| 143 | behavioral defense response (GO:0002209) | 3.00513757 |
| 144 | behavioral fear response (GO:0001662) | 3.00513757 |
| 145 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.00302790 |
| 146 | regulation of neurotransmitter levels (GO:0001505) | 3.00212966 |
| 147 | protein deneddylation (GO:0000338) | 3.00121025 |
| 148 | response to histamine (GO:0034776) | 2.99516878 |
| 149 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.98983875 |
| 150 | phenol-containing compound metabolic process (GO:0018958) | 2.98885668 |
| 151 | cyclic nucleotide catabolic process (GO:0009214) | 2.98330129 |
| 152 | centrosome duplication (GO:0051298) | 2.97479555 |
| 153 | membrane depolarization during action potential (GO:0086010) | 2.97271512 |
| 154 | female mating behavior (GO:0060180) | 2.96297269 |
| 155 | acrosome reaction (GO:0007340) | 2.94838445 |
| 156 | positive regulation of synapse maturation (GO:0090129) | 2.94592203 |
| 157 | vesicle transport along microtubule (GO:0047496) | 2.93053089 |
| 158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92883594 |
| 159 | DNA methylation involved in gamete generation (GO:0043046) | 2.92514664 |
| 160 | auditory receptor cell stereocilium organization (GO:0060088) | 2.91898214 |
| 161 | negative regulation of dendrite development (GO:2000171) | 2.91882825 |
| 162 | cellular potassium ion homeostasis (GO:0030007) | 2.91084095 |
| 163 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.90349629 |
| 164 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.90024396 |
| 165 | proline transport (GO:0015824) | 2.89860646 |
| 166 | synaptic vesicle endocytosis (GO:0048488) | 2.88824078 |
| 167 | visual behavior (GO:0007632) | 2.88228633 |
| 168 | regulation of early endosome to late endosome transport (GO:2000641) | 2.86744757 |
| 169 | male meiosis (GO:0007140) | 2.84151624 |
| 170 | protein K11-linked deubiquitination (GO:0035871) | 2.83764404 |
| 171 | regulation of sulfur metabolic process (GO:0042762) | 2.78824168 |
| 172 | negative regulation of membrane potential (GO:0045837) | 2.77561143 |
| 173 | regulation of neurotransmitter uptake (GO:0051580) | 2.76143454 |
| 174 | kinetochore assembly (GO:0051382) | 2.75614862 |
| 175 | cellular response to epinephrine stimulus (GO:0071872) | 2.65979192 |
| 176 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.65247333 |
| 177 | regulation of coenzyme metabolic process (GO:0051196) | 2.65081470 |
| 178 | regulation of cofactor metabolic process (GO:0051193) | 2.65081470 |
| 179 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.63844570 |
| 180 | regulation of superoxide metabolic process (GO:0090322) | 2.62788641 |
| 181 | galactose metabolic process (GO:0006012) | 2.62194396 |
| 182 | cornea development in camera-type eye (GO:0061303) | 2.62190304 |
| 183 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 2.60814044 |
| 184 | negative regulation of chemokine production (GO:0032682) | 2.60645398 |
| 185 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.59779975 |
| 186 | sympathetic nervous system development (GO:0048485) | 2.59370323 |
| 187 | short-chain fatty acid metabolic process (GO:0046459) | 2.56675864 |
| 188 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.56566774 |
| 189 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54452795 |
| 190 | kinetochore organization (GO:0051383) | 2.52016463 |
| 191 | endosome to melanosome transport (GO:0035646) | 2.51499890 |
| 192 | endosome to pigment granule transport (GO:0043485) | 2.51499890 |
| 193 | myelin assembly (GO:0032288) | 2.51370405 |
| 194 | regulation of myelination (GO:0031641) | 2.50156457 |
| 195 | melanin biosynthetic process (GO:0042438) | 19.9917368 |
| 196 | melanin metabolic process (GO:0006582) | 18.3653851 |
| 197 | secondary metabolite biosynthetic process (GO:0044550) | 17.1087463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.02033811 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.48536734 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.48982924 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.52507620 |
| 5 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.43905781 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.23306450 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14196305 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.13295014 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01523349 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93520819 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79324138 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71595370 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64589251 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62988166 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62988166 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57845833 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56181059 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 2.53805043 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51928871 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51835109 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.50937894 |
| 22 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50711724 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49347269 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.42416057 |
| 25 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33174445 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29483214 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26462491 |
| 28 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23663069 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19942571 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15684964 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14996508 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.14924815 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10818173 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.10305964 |
| 35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10156670 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.98883640 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92272852 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90373826 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90217779 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82953325 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80310335 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79082319 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.78809896 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78312503 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77127878 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.77056942 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76781633 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.74525469 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.73952912 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.71094774 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70384975 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65719680 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63510932 |
| 54 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.60893086 |
| 55 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58593246 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57704714 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.56232683 |
| 58 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55642832 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.53833793 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48551687 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47956496 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47956496 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47891775 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47766807 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43164458 |
| 66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42324213 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41672731 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.40128542 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38666513 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37838035 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37730479 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36050621 |
| 73 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35762629 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35351669 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34416133 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34174686 |
| 77 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32365998 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31274078 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30374749 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30078304 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29228233 |
| 82 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27769184 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.27580245 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27443640 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26714970 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26673958 |
| 87 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.23032055 |
| 88 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22481568 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21544338 |
| 90 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21519424 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21326374 |
| 92 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21041841 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20744513 |
| 94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19932370 |
| 95 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18905834 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.18868760 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18298404 |
| 98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18155668 |
| 99 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18098402 |
| 100 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17912223 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17628434 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17177988 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16950901 |
| 104 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.16599889 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15259496 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14163317 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14105555 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13876414 |
| 109 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13032798 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10852287 |
| 111 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.10750257 |
| 112 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10719903 |
| 113 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10594871 |
| 114 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.10462674 |
| 115 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.10377670 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10365763 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10321110 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10125475 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09321037 |
| 120 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09144886 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 1.09015402 |
| 122 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.08987248 |
| 123 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08239700 |
| 124 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.07194314 |
| 125 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06686898 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06331558 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06156822 |
| 128 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04754186 |
| 129 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04460244 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04192354 |
| 131 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03918899 |
| 132 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03029436 |
| 133 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02952200 |
| 134 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.02925177 |
| 135 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02182777 |
| 136 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.01805539 |
| 137 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01399923 |
| 138 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01281328 |
| 139 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01107007 |
| 140 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00068816 |
| 141 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99440790 |
| 142 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99187028 |
| 143 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99175252 |
| 144 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98748329 |
| 145 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98556091 |
| 146 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98318841 |
| 147 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98117057 |
| 148 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97898137 |
| 149 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.97831115 |
| 150 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97758752 |
| 151 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97757494 |
| 152 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97751553 |
| 153 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97667208 |
| 154 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96669820 |
| 155 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96598233 |
| 156 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96394526 |
| 157 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95454747 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95405807 |
| 159 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95236696 |
| 160 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93927001 |
| 161 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93822897 |
| 162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91939454 |
| 163 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90925276 |
| 164 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88400193 |
| 165 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87157522 |
| 166 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86742054 |
| 167 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86455863 |
| 168 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86091751 |
| 169 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86017647 |
| 170 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85710548 |
| 171 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84868028 |
| 172 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84467386 |
| 173 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83493627 |
| 174 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81985955 |
| 175 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80678494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.22360108 |
| 2 | MP0005408_hypopigmentation | 5.87802435 |
| 3 | MP0003136_yellow_coat_color | 5.74911660 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 5.19287019 |
| 5 | MP0002822_catalepsy | 5.07226284 |
| 6 | MP0000015_abnormal_ear_pigmentation | 4.70560603 |
| 7 | MP0003880_abnormal_central_pattern | 4.58188491 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 4.03926685 |
| 9 | MP0004270_analgesia | 3.84771245 |
| 10 | MP0002095_abnormal_skin_pigmentation | 3.66081376 |
| 11 | MP0002102_abnormal_ear_morphology | 3.48643103 |
| 12 | MP0009745_abnormal_behavioral_response | 3.43331059 |
| 13 | MP0000371_diluted_coat_color | 3.41021466 |
| 14 | MP0003646_muscle_fatigue | 3.33968371 |
| 15 | MP0002063_abnormal_learning/memory/cond | 3.33575044 |
| 16 | MP0002064_seizures | 3.04652340 |
| 17 | MP0004381_abnormal_hair_follicle | 2.96923117 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.80748960 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.78148195 |
| 20 | MP0009046_muscle_twitch | 2.68749555 |
| 21 | MP0001486_abnormal_startle_reflex | 2.65576318 |
| 22 | MP0001324_abnormal_eye_pigmentation | 2.63225814 |
| 23 | MP0002272_abnormal_nervous_system | 2.62774909 |
| 24 | MP0005174_abnormal_tail_pigmentation | 2.61710384 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 2.58181777 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.53725292 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.52805468 |
| 28 | MP0005423_abnormal_somatic_nervous | 2.41483135 |
| 29 | MP0002938_white_spotting | 2.33103605 |
| 30 | MP0002909_abnormal_adrenal_gland | 2.30155910 |
| 31 | MP0003878_abnormal_ear_physiology | 2.26640997 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 2.26640997 |
| 33 | MP0005646_abnormal_pituitary_gland | 2.18913311 |
| 34 | MP0002736_abnormal_nociception_after | 2.09034949 |
| 35 | MP0001501_abnormal_sleep_pattern | 2.08259104 |
| 36 | MP0000372_irregular_coat_pigmentation | 10.5768784 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.98972400 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.96327586 |
| 39 | MP0001529_abnormal_vocalization | 1.94886146 |
| 40 | MP0001970_abnormal_pain_threshold | 1.93358526 |
| 41 | MP0002075_abnormal_coat/hair_pigmentati | 1.87004893 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.85927833 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.85011122 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.80631387 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.75617502 |
| 46 | MP0004924_abnormal_behavior | 1.75617502 |
| 47 | MP0008569_lethality_at_weaning | 1.75596117 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.75017452 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.72730643 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.69226624 |
| 51 | MP0003879_abnormal_hair_cell | 1.63898754 |
| 52 | MP0001984_abnormal_olfaction | 1.60715809 |
| 53 | MP0003329_amyloid_beta_deposits | 1.59218177 |
| 54 | MP0001186_pigmentation_phenotype | 1.59171718 |
| 55 | MP0000778_abnormal_nervous_system | 1.50152371 |
| 56 | MP0002184_abnormal_innervation | 1.48159650 |
| 57 | MP0003283_abnormal_digestive_organ | 1.46620866 |
| 58 | MP0000955_abnormal_spinal_cord | 1.44387725 |
| 59 | MP0001188_hyperpigmentation | 1.43960678 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.43824930 |
| 61 | MP0004885_abnormal_endolymph | 1.43530066 |
| 62 | MP0003633_abnormal_nervous_system | 1.38258231 |
| 63 | MP0005253_abnormal_eye_physiology | 1.37219443 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.36659571 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.36497404 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.35350511 |
| 67 | MP0004043_abnormal_pH_regulation | 1.33134005 |
| 68 | MP0001905_abnormal_dopamine_level | 1.33015722 |
| 69 | MP0002882_abnormal_neuron_morphology | 1.32257726 |
| 70 | MP0003787_abnormal_imprinting | 1.32063204 |
| 71 | MP0004858_abnormal_nervous_system | 1.30588857 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.30133967 |
| 73 | MP0005248_abnormal_Harderian_gland | 1.28582931 |
| 74 | MP0005409_darkened_coat_color | 1.22705041 |
| 75 | MP0010386_abnormal_urinary_bladder | 1.14065703 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 1.13570961 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.12117438 |
| 78 | MP0003631_nervous_system_phenotype | 1.09459684 |
| 79 | MP0005197_abnormal_uvea_morphology | 1.07406126 |
| 80 | MP0004142_abnormal_muscle_tone | 1.02179620 |
| 81 | MP0001177_atelectasis | 1.01554834 |
| 82 | MP0000920_abnormal_myelination | 1.01064199 |
| 83 | MP0002229_neurodegeneration | 0.99673081 |
| 84 | MP0003075_altered_response_to | 0.99609922 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.97078946 |
| 86 | MP0008874_decreased_physiological_sensi | 0.96880799 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.96626949 |
| 88 | MP0005535_abnormal_body_temperature | 0.96492941 |
| 89 | MP0002152_abnormal_brain_morphology | 0.96069497 |
| 90 | MP0004085_abnormal_heartbeat | 0.92449375 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.91416859 |
| 92 | MP0005187_abnormal_penis_morphology | 0.90904426 |
| 93 | MP0003690_abnormal_glial_cell | 0.90425632 |
| 94 | MP0003634_abnormal_glial_cell | 0.90226580 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 0.89041261 |
| 96 | MP0008872_abnormal_physiological_respon | 0.88107592 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.87740447 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 0.83379982 |
| 99 | MP0002090_abnormal_vision | 0.82581653 |
| 100 | MP0003122_maternal_imprinting | 0.81012771 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.80345919 |
| 102 | MP0004742_abnormal_vestibular_system | 0.78591787 |
| 103 | MP0002837_dystrophic_cardiac_calcinosis | 0.78399576 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.78179674 |
| 105 | MP0005499_abnormal_olfactory_system | 0.78179674 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.77585207 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.75907446 |
| 108 | MP0004233_abnormal_muscle_weight | 0.75023413 |
| 109 | MP0008058_abnormal_DNA_repair | 0.74958786 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.74296729 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.73813244 |
| 112 | MP0001664_abnormal_digestion | 0.73113569 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.73014246 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.71444806 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.68709838 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.67945567 |
| 117 | MP0003632_abnormal_nervous_system | 0.66688304 |
| 118 | MP0000751_myopathy | 0.65712145 |
| 119 | MP0003718_maternal_effect | 0.65124585 |
| 120 | MP0002752_abnormal_somatic_nervous | 0.63426300 |
| 121 | MP0004484_altered_response_of | 0.62287633 |
| 122 | MP0005171_absent_coat_pigmentation | 0.60786504 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.59458769 |
| 124 | MP0000604_amyloidosis | 0.59313198 |
| 125 | MP0003186_abnormal_redox_activity | 0.58388587 |
| 126 | MP0003111_abnormal_nucleus_morphology | 0.57449192 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.57285542 |
| 128 | MP0002177_abnormal_outer_ear | 0.56969640 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.55144941 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.54681280 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.54596194 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.53686095 |
| 133 | MP0000749_muscle_degeneration | 0.52398889 |
| 134 | MP0001943_abnormal_respiration | 0.51148700 |
| 135 | MP0001299_abnormal_eye_distance/ | 0.50863838 |
| 136 | MP0000647_abnormal_sebaceous_gland | 0.50837806 |
| 137 | MP0005391_vision/eye_phenotype | 0.50740123 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.50102877 |
| 139 | MP0000427_abnormal_hair_cycle | 0.48540827 |
| 140 | MP0004147_increased_porphyrin_level | 0.47882429 |
| 141 | MP0006138_congestive_heart_failure | 0.41859513 |
| 142 | MP0006054_spinal_hemorrhage | 0.38524365 |
| 143 | MP0010678_abnormal_skin_adnexa | 0.36472112 |
| 144 | MP0008877_abnormal_DNA_methylation | 0.36237180 |
| 145 | MP0003077_abnormal_cell_cycle | 0.35234088 |
| 146 | MP0008057_abnormal_DNA_replication | 0.35177038 |
| 147 | MP0005193_abnormal_anterior_eye | 0.33681235 |
| 148 | MP0002396_abnormal_hematopoietic_system | 0.32596252 |
| 149 | MP0005195_abnormal_posterior_eye | 0.32303605 |
| 150 | MP0003195_calcinosis | 0.30662779 |
| 151 | MP0000367_abnormal_coat/_hair | 0.29678293 |
| 152 | MP0002282_abnormal_trachea_morphology | 0.26903051 |
| 153 | MP0005389_reproductive_system_phenotype | 0.20047860 |
| 154 | MP0005165_increased_susceptibility_to | 0.19453682 |
| 155 | MP0001919_abnormal_reproductive_system | 0.18661511 |
| 156 | MP0003698_abnormal_male_reproductive | 0.18610627 |
| 157 | MP0000026_abnormal_inner_ear | 0.16877497 |
| 158 | MP0001929_abnormal_gametogenesis | 0.14725234 |
| 159 | MP0000516_abnormal_urinary_system | 0.14518799 |
| 160 | MP0005367_renal/urinary_system_phenotyp | 0.14518799 |
| 161 | MP0002751_abnormal_autonomic_nervous | 0.12449602 |
| 162 | MP0000358_abnormal_cell_content/ | 0.12293232 |
| 163 | MP0003943_abnormal_hepatobiliary_system | 0.12186503 |
| 164 | MP0009115_abnormal_fat_cell | 0.11623424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/Hypoplasia of the macula (HP:0008059) | 9.85972318 |
| 2 | Ocular albinism (HP:0001107) | 9.66510606 |
| 3 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 9.15427407 |
| 4 | Iris hypopigmentation (HP:0007730) | 8.75645020 |
| 5 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 7.77152168 |
| 6 | Hypoplasia of the fovea (HP:0007750) | 7.77152168 |
| 7 | Focal motor seizures (HP:0011153) | 7.75060678 |
| 8 | Myokymia (HP:0002411) | 7.55559508 |
| 9 | Abnormality of the fovea (HP:0000493) | 6.83327484 |
| 10 | White forelock (HP:0002211) | 6.44215341 |
| 11 | Congenital stationary night blindness (HP:0007642) | 6.32849124 |
| 12 | Patchy hypopigmentation of hair (HP:0011365) | 6.32292221 |
| 13 | Generalized hypopigmentation (HP:0007513) | 6.00685025 |
| 14 | Hypopigmentation of the fundus (HP:0007894) | 5.96345759 |
| 15 | Focal seizures (HP:0007359) | 5.48106107 |
| 16 | Visual hallucinations (HP:0002367) | 5.22160397 |
| 17 | Decreased central vision (HP:0007663) | 4.89392523 |
| 18 | Abnormal auditory evoked potentials (HP:0006958) | 4.68718893 |
| 19 | Epileptic encephalopathy (HP:0200134) | 4.56192917 |
| 20 | Freckling (HP:0001480) | 4.32371680 |
| 21 | Albinism (HP:0001022) | 4.31719393 |
| 22 | Cutaneous melanoma (HP:0012056) | 4.27754872 |
| 23 | Atonic seizures (HP:0010819) | 4.02642532 |
| 24 | Ankle clonus (HP:0011448) | 3.86495072 |
| 25 | Febrile seizures (HP:0002373) | 3.85049839 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 3.62219684 |
| 27 | Congenital sensorineural hearing impairment (HP:0008527) | 3.61693854 |
| 28 | Action tremor (HP:0002345) | 3.61090520 |
| 29 | Absence seizures (HP:0002121) | 3.60799410 |
| 30 | Poor eye contact (HP:0000817) | 3.50608296 |
| 31 | Broad-based gait (HP:0002136) | 3.50498999 |
| 32 | Dialeptic seizures (HP:0011146) | 3.46355363 |
| 33 | Depression (HP:0000716) | 3.41379900 |
| 34 | Anxiety (HP:0000739) | 3.40270374 |
| 35 | Progressive cerebellar ataxia (HP:0002073) | 3.37997175 |
| 36 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 3.34690610 |
| 37 | Heterochromia iridis (HP:0001100) | 3.30299855 |
| 38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.28033183 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 3.26617212 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 3.25656334 |
| 41 | Torticollis (HP:0000473) | 3.22780449 |
| 42 | Horizontal nystagmus (HP:0000666) | 3.21962207 |
| 43 | Hyperventilation (HP:0002883) | 3.15028329 |
| 44 | Abnormal social behavior (HP:0012433) | 3.06202355 |
| 45 | Impaired social interactions (HP:0000735) | 3.06202355 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05959565 |
| 47 | Premature graying of hair (HP:0002216) | 3.05771757 |
| 48 | Dysdiadochokinesis (HP:0002075) | 3.01960323 |
| 49 | Generalized hypopigmentation of hair (HP:0011358) | 3.01267807 |
| 50 | Resting tremor (HP:0002322) | 2.99636497 |
| 51 | Dysmetria (HP:0001310) | 2.98794639 |
| 52 | Fibular hypoplasia (HP:0003038) | 2.92306280 |
| 53 | Papilledema (HP:0001085) | 2.92139105 |
| 54 | Truncal ataxia (HP:0002078) | 2.91119080 |
| 55 | Focal dystonia (HP:0004373) | 2.88816856 |
| 56 | Frequent falls (HP:0002359) | 2.85950729 |
| 57 | Intestinal atresia (HP:0011100) | 2.83639849 |
| 58 | Annular pancreas (HP:0001734) | 2.77674259 |
| 59 | Amblyopia (HP:0000646) | 2.76651757 |
| 60 | Spastic gait (HP:0002064) | 2.76274037 |
| 61 | Postural instability (HP:0002172) | 2.73673025 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.71133240 |
| 63 | Scanning speech (HP:0002168) | 2.69815218 |
| 64 | Craniofacial dystonia (HP:0012179) | 2.69094935 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.68292900 |
| 66 | Impaired smooth pursuit (HP:0007772) | 2.64439597 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.60603109 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.59916824 |
| 69 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.59248316 |
| 70 | Stereotypic behavior (HP:0000733) | 2.58264410 |
| 71 | Dyschromatopsia (HP:0007641) | 2.58028096 |
| 72 | Urinary urgency (HP:0000012) | 2.57213100 |
| 73 | Megalencephaly (HP:0001355) | 2.51641481 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.51554332 |
| 75 | Hypoplasia of the iris (HP:0007676) | 2.43578600 |
| 76 | Astigmatism (HP:0000483) | 2.43324435 |
| 77 | Degeneration of anterior horn cells (HP:0002398) | 2.41737927 |
| 78 | Abnormality of the anterior horn cell (HP:0006802) | 2.41737927 |
| 79 | Limb dystonia (HP:0002451) | 2.40240863 |
| 80 | Intention tremor (HP:0002080) | 2.39469651 |
| 81 | Impaired vibratory sensation (HP:0002495) | 2.38454890 |
| 82 | Excessive salivation (HP:0003781) | 2.37484008 |
| 83 | Drooling (HP:0002307) | 2.37484008 |
| 84 | Insidious onset (HP:0003587) | 2.36143496 |
| 85 | Termporal pattern (HP:0011008) | 2.36143496 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.35687713 |
| 87 | Bradykinesia (HP:0002067) | 2.35551986 |
| 88 | Hemiparesis (HP:0001269) | 2.33234722 |
| 89 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.32652189 |
| 90 | Facial cleft (HP:0002006) | 2.32340753 |
| 91 | Pheochromocytoma (HP:0002666) | 2.29908055 |
| 92 | Clonus (HP:0002169) | 2.27841277 |
| 93 | Mutism (HP:0002300) | 2.22660722 |
| 94 | Dysmetric saccades (HP:0000641) | 2.22168549 |
| 95 | Hamartoma of the eye (HP:0010568) | 2.20647732 |
| 96 | Lower limb muscle weakness (HP:0007340) | 2.20410171 |
| 97 | Genetic anticipation (HP:0003743) | 2.17683860 |
| 98 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.16337733 |
| 99 | Prolonged QT interval (HP:0001657) | 2.16193348 |
| 100 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.13645055 |
| 101 | Progressive inability to walk (HP:0002505) | 2.13583444 |
| 102 | Absent speech (HP:0001344) | 2.12422686 |
| 103 | Abnormal EKG (HP:0003115) | 2.11916717 |
| 104 | Abnormality of the corticospinal tract (HP:0002492) | 2.11714974 |
| 105 | Abnormality of glycolysis (HP:0004366) | 2.11579137 |
| 106 | Adrenal hypoplasia (HP:0000835) | 2.09538901 |
| 107 | Blue irides (HP:0000635) | 2.04493413 |
| 108 | Bifid tongue (HP:0010297) | 2.03544464 |
| 109 | Ankyloglossia (HP:0010296) | 2.03404898 |
| 110 | Diplopia (HP:0000651) | 2.01189783 |
| 111 | Abnormality of binocular vision (HP:0011514) | 2.01189783 |
| 112 | Progressive macrocephaly (HP:0004481) | 1.99951935 |
| 113 | Gait imbalance (HP:0002141) | 1.99424987 |
| 114 | Incomplete penetrance (HP:0003829) | 1.99066181 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.94980438 |
| 116 | Acute necrotizing encephalopathy (HP:0006965) | 1.94947827 |
| 117 | Tongue fasciculations (HP:0001308) | 1.94936911 |
| 118 | Fetal akinesia sequence (HP:0001989) | 1.94922211 |
| 119 | Increased CSF lactate (HP:0002490) | 1.94671488 |
| 120 | Ventricular fibrillation (HP:0001663) | 1.94439403 |
| 121 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.93439262 |
| 122 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.93439262 |
| 123 | Gait ataxia (HP:0002066) | 1.93077488 |
| 124 | Epidermoid cyst (HP:0200040) | 1.92701960 |
| 125 | Abnormality of the lower motor neuron (HP:0002366) | 1.92539389 |
| 126 | Generalized myoclonic seizures (HP:0002123) | 1.91090872 |
| 127 | Pointed chin (HP:0000307) | 1.90888782 |
| 128 | Neuroendocrine neoplasm (HP:0100634) | 1.90314473 |
| 129 | Bundle branch block (HP:0011710) | 1.90008558 |
| 130 | Subaortic stenosis (HP:0001682) | 1.84625321 |
| 131 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.84625321 |
| 132 | Cortical visual impairment (HP:0100704) | 1.84407889 |
| 133 | Enlarged kidneys (HP:0000105) | 1.83733601 |
| 134 | Mitochondrial inheritance (HP:0001427) | 1.83608290 |
| 135 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83565652 |
| 136 | Acute encephalopathy (HP:0006846) | 1.83424247 |
| 137 | Agitation (HP:0000713) | 1.83178008 |
| 138 | Abnormality of the periventricular white matter (HP:0002518) | 1.82799958 |
| 139 | Melanoma (HP:0002861) | 1.82386388 |
| 140 | Median cleft lip (HP:0000161) | 1.80448332 |
| 141 | Long clavicles (HP:0000890) | 1.80334006 |
| 142 | Status epilepticus (HP:0002133) | 1.80271715 |
| 143 | Abnormality of saccadic eye movements (HP:0000570) | 1.77707616 |
| 144 | Rigidity (HP:0002063) | 1.77341278 |
| 145 | Neuronal loss in central nervous system (HP:0002529) | 1.77281724 |
| 146 | Hemiplegia (HP:0002301) | 1.76710300 |
| 147 | Inability to walk (HP:0002540) | 1.76505576 |
| 148 | Photophobia (HP:0000613) | 1.75267215 |
| 149 | Spinal canal stenosis (HP:0003416) | 1.74314100 |
| 150 | Obstructive sleep apnea (HP:0002870) | 1.73037580 |
| 151 | Specific learning disability (HP:0001328) | 1.72922015 |
| 152 | Insomnia (HP:0100785) | 1.72328172 |
| 153 | Abnormal gallbladder physiology (HP:0012438) | 1.71309990 |
| 154 | Cholecystitis (HP:0001082) | 1.71309990 |
| 155 | Thickened helices (HP:0000391) | 1.70881196 |
| 156 | Hypokinesia (HP:0002375) | 1.69264988 |
| 157 | Ependymoma (HP:0002888) | 1.68745459 |
| 158 | Poor head control (HP:0002421) | 1.67708365 |
| 159 | Neoplasm of the adrenal cortex (HP:0100641) | 1.64914618 |
| 160 | Muscle fibrillation (HP:0010546) | 1.63841348 |
| 161 | Volvulus (HP:0002580) | 1.63132823 |
| 162 | Hepatocellular necrosis (HP:0001404) | 1.61563884 |
| 163 | Abnormality of chromosome stability (HP:0003220) | 1.58366430 |
| 164 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.57139647 |
| 165 | Abnormality of the astrocytes (HP:0100707) | 1.54573618 |
| 166 | Astrocytoma (HP:0009592) | 1.54573618 |
| 167 | Abnormality of the pupil (HP:0000615) | 1.54553662 |
| 168 | Chromsome breakage (HP:0040012) | 1.50617179 |
| 169 | Increased intramyocellular lipid droplets (HP:0012240) | 1.50203847 |
| 170 | Small hand (HP:0200055) | 1.47970758 |
| 171 | Increased hepatocellular lipid droplets (HP:0006565) | 1.47380873 |
| 172 | Renal Fanconi syndrome (HP:0001994) | 1.44587675 |
| 173 | Spastic paraparesis (HP:0002313) | 1.44212503 |
| 174 | Small intestinal stenosis (HP:0012848) | 1.43625801 |
| 175 | Duodenal stenosis (HP:0100867) | 1.43625801 |
| 176 | Lipid accumulation in hepatocytes (HP:0006561) | 1.42812385 |
| 177 | Aplasia cutis congenita (HP:0001057) | 1.42239343 |
| 178 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.41918703 |
| 179 | Abnormality of macular pigmentation (HP:0008002) | 1.41794208 |
| 180 | Delusions (HP:0000746) | 1.39828513 |
| 181 | Spinal muscular atrophy (HP:0007269) | 1.39525004 |
| 182 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.39094475 |
| 183 | Hepatic necrosis (HP:0002605) | 1.37591604 |
| 184 | Neoplasm of the heart (HP:0100544) | 1.37538444 |
| 185 | Gastrointestinal atresia (HP:0002589) | 1.37279808 |
| 186 | Vitreoretinal degeneration (HP:0000655) | 1.36710249 |
| 187 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.31755662 |
| 188 | Abnormal lung lobation (HP:0002101) | 1.31485807 |
| 189 | Renal dysplasia (HP:0000110) | 1.30234711 |
| 190 | Neoplasm of the adrenal gland (HP:0100631) | 1.29041810 |
| 191 | Cerebral edema (HP:0002181) | 1.27298768 |
| 192 | Increased serum pyruvate (HP:0003542) | 1.27084130 |
| 193 | Abnormality of chromosome segregation (HP:0002916) | 1.26182214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.99497098 |
| 2 | WEE1 | 5.33253275 |
| 3 | NTRK3 | 4.23771088 |
| 4 | PDK2 | 4.18454230 |
| 5 | FRK | 3.88732368 |
| 6 | EIF2AK1 | 3.67361804 |
| 7 | MST1R | 3.65456204 |
| 8 | MAP3K9 | 3.29725142 |
| 9 | TRIM28 | 3.14725385 |
| 10 | BMPR1B | 3.02334592 |
| 11 | DAPK2 | 2.97884396 |
| 12 | MARK3 | 2.63177749 |
| 13 | PRKD3 | 2.63144904 |
| 14 | ACVR1B | 2.54128145 |
| 15 | MARK1 | 2.41047309 |
| 16 | MAP3K4 | 2.40597990 |
| 17 | KSR2 | 2.24723417 |
| 18 | GRK6 | 2.18151619 |
| 19 | MINK1 | 2.17685267 |
| 20 | EIF2AK3 | 2.15900646 |
| 21 | SIK3 | 2.13195566 |
| 22 | RIPK4 | 2.12725378 |
| 23 | MAP2K7 | 2.08345802 |
| 24 | CASK | 2.07092327 |
| 25 | NTRK1 | 2.05841504 |
| 26 | PLK3 | 2.05738273 |
| 27 | ERBB3 | 2.01596643 |
| 28 | CAMKK1 | 1.98721521 |
| 29 | PAK6 | 1.89862219 |
| 30 | PRPF4B | 1.78019707 |
| 31 | NTRK2 | 1.71425640 |
| 32 | MAP3K2 | 1.69043747 |
| 33 | DAPK1 | 1.65431587 |
| 34 | TNIK | 1.65247184 |
| 35 | CDK5 | 1.63192891 |
| 36 | CAMKK2 | 1.58584422 |
| 37 | FER | 1.56744241 |
| 38 | ARAF | 1.50598204 |
| 39 | KSR1 | 1.46356918 |
| 40 | FES | 1.40522461 |
| 41 | MAP3K13 | 1.37252860 |
| 42 | CDK19 | 1.36591905 |
| 43 | MAP2K4 | 1.35343432 |
| 44 | CSNK1G3 | 1.32815522 |
| 45 | TGFBR2 | 1.28748697 |
| 46 | INSRR | 1.27279339 |
| 47 | MAP3K12 | 1.27130272 |
| 48 | SGK223 | 1.25625533 |
| 49 | SGK494 | 1.25625533 |
| 50 | UHMK1 | 1.18063953 |
| 51 | MAPK13 | 1.15115798 |
| 52 | CSNK1A1L | 1.13994589 |
| 53 | TYRO3 | 1.13597208 |
| 54 | BMPR2 | 1.12238220 |
| 55 | GRK5 | 1.11756169 |
| 56 | PLK2 | 1.10586534 |
| 57 | SIK2 | 1.06741216 |
| 58 | TAOK1 | 1.06713308 |
| 59 | MET | 1.05311149 |
| 60 | CSNK1G1 | 1.04195770 |
| 61 | PRKCG | 1.02378029 |
| 62 | OXSR1 | 1.00669679 |
| 63 | PRKCH | 1.00513843 |
| 64 | LATS1 | 0.98650346 |
| 65 | SGK2 | 0.98437955 |
| 66 | ADRBK1 | 0.97971196 |
| 67 | CAMK2A | 0.94588649 |
| 68 | CAMK2B | 0.93469098 |
| 69 | STK38 | 0.92993662 |
| 70 | ATR | 0.91565785 |
| 71 | PINK1 | 0.89796901 |
| 72 | MAP3K1 | 0.87341045 |
| 73 | MAP4K2 | 0.86762277 |
| 74 | MARK2 | 0.85224430 |
| 75 | NEK6 | 0.84884930 |
| 76 | PLK4 | 0.84260772 |
| 77 | CDK18 | 0.83765026 |
| 78 | CDK15 | 0.81868253 |
| 79 | CDK14 | 0.81194500 |
| 80 | STK11 | 0.80836563 |
| 81 | SGK3 | 0.80813336 |
| 82 | STK3 | 0.80091669 |
| 83 | RAF1 | 0.79975137 |
| 84 | CAMK1 | 0.79718204 |
| 85 | PLK1 | 0.79107608 |
| 86 | MAP3K3 | 0.78280707 |
| 87 | SGK1 | 0.76839066 |
| 88 | PRKAA2 | 0.75669937 |
| 89 | RET | 0.74384954 |
| 90 | PTK2B | 0.72794326 |
| 91 | PDPK1 | 0.72433900 |
| 92 | PRKD1 | 0.71984042 |
| 93 | CDK11A | 0.71142609 |
| 94 | CSNK1D | 0.70512823 |
| 95 | NUAK1 | 0.68886203 |
| 96 | NEK1 | 0.67719139 |
| 97 | BCKDK | 0.67217880 |
| 98 | ADRBK2 | 0.67104400 |
| 99 | PDK1 | 0.66546437 |
| 100 | AKT3 | 0.63548121 |
| 101 | PHKG1 | 0.62983334 |
| 102 | PHKG2 | 0.62983334 |
| 103 | PNCK | 0.62836682 |
| 104 | CDC7 | 0.62655174 |
| 105 | PRKCE | 0.61444522 |
| 106 | AKT2 | 0.58653640 |
| 107 | PAK3 | 0.58195148 |
| 108 | EIF2AK2 | 0.57326844 |
| 109 | ATM | 0.56332899 |
| 110 | BRAF | 0.55743485 |
| 111 | CAMK2D | 0.54459381 |
| 112 | CDK3 | 0.54278715 |
| 113 | TNK2 | 0.53975753 |
| 114 | CSNK1A1 | 0.53356171 |
| 115 | KIT | 0.53260096 |
| 116 | CDC42BPA | 0.52989362 |
| 117 | DYRK1A | 0.52901378 |
| 118 | TGFBR1 | 0.52825077 |
| 119 | GSK3A | 0.52595430 |
| 120 | CSNK1G2 | 0.51558695 |
| 121 | ZAK | 0.51168705 |
| 122 | BRSK2 | 0.50103336 |
| 123 | ALK | 0.49810942 |
| 124 | BUB1 | 0.49282259 |
| 125 | RPS6KA3 | 0.49206615 |
| 126 | WNK1 | 0.48499095 |
| 127 | MAP2K1 | 0.47321246 |
| 128 | CAMK4 | 0.46451971 |
| 129 | PRKCZ | 0.46071761 |
| 130 | DAPK3 | 0.45725532 |
| 131 | FYN | 0.45431270 |
| 132 | CCNB1 | 0.44735776 |
| 133 | PRKD2 | 0.43488254 |
| 134 | CHEK2 | 0.43436142 |
| 135 | WNK4 | 0.42921501 |
| 136 | CAMK2G | 0.42681168 |
| 137 | WNK3 | 0.41761920 |
| 138 | HIPK2 | 0.41313883 |
| 139 | MATK | 0.40019453 |
| 140 | SYK | 0.39771267 |
| 141 | GRK1 | 0.39615230 |
| 142 | CDK7 | 0.39198618 |
| 143 | BCR | 0.38480780 |
| 144 | STK39 | 0.37854076 |
| 145 | RPS6KA2 | 0.36764818 |
| 146 | EGFR | 0.35258745 |
| 147 | FGFR2 | 0.35041074 |
| 148 | MAPKAPK5 | 0.35040519 |
| 149 | DMPK | 0.34799758 |
| 150 | LMTK2 | 0.34568407 |
| 151 | FGR | 0.34163450 |
| 152 | * MAPK10 | 0.33764703 |
| 153 | BRSK1 | 0.33614536 |
| 154 | ABL2 | 0.27097912 |
| 155 | TYK2 | 0.25970239 |
| 156 | IGF1R | 0.25928671 |
| 157 | NEK2 | 0.25909259 |
| 158 | PRKACA | 0.25434940 |
| 159 | MAPKAPK3 | 0.23582881 |
| 160 | CSNK2A1 | 0.23218708 |
| 161 | MKNK2 | 0.22558303 |
| 162 | STK38L | 0.22520053 |
| 163 | ABL1 | 0.21977592 |
| 164 | IKBKB | 0.19670578 |
| 165 | LYN | 0.19505568 |
| 166 | TAOK3 | 0.18905434 |
| 167 | TSSK6 | 0.18782422 |
| 168 | PRKACB | 0.18638845 |
| 169 | FGFR3 | 0.17427466 |
| 170 | PRKDC | 0.16153677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 4.66609612 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.58164238 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 3.57521789 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.36493188 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 3.15964794 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12840728 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 3.08845107 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 3.05974078 |
| 9 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.03522467 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.79089244 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.77867057 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.70931197 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68927166 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.68139249 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66469672 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64194626 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.53631253 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53206161 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 2.35853737 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.32825920 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 2.22609198 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.16939639 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.10227943 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 2.04041805 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95820142 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95764144 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95090444 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94509789 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88373321 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.83360273 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.82258623 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.80320803 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.79894172 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76920402 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76168327 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74992227 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74371294 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.69596103 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64012217 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.62863985 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61537816 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60880003 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.59105637 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56581302 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55558296 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.54849166 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53229440 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.48023862 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45935642 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.41116187 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39000327 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37968328 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37835021 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35660019 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34296634 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32294661 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.30053626 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28966112 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25793090 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23724632 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18183668 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16324328 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15896789 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15411343 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08401083 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07514684 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06573386 |
| 68 | Glioma_Homo sapiens_hsa05214 | 1.06230442 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04944266 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 1.04772353 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04687642 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03011014 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01648753 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.97951425 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.96790131 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96238151 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95275897 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94819008 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91867796 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90726600 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90114679 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89683494 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.87922895 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87190369 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84305930 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84191532 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83627509 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82881963 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.82719652 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82685684 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80726972 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80451126 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80237483 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79929740 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78730155 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77809942 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76517490 |
| 98 | RNA transport_Homo sapiens_hsa03013 | 0.75899069 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.75594969 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75230786 |
| 101 | DNA replication_Homo sapiens_hsa03030 | 0.73915749 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73222720 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73199879 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71860430 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70031362 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69256249 |
| 107 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69059468 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68926424 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68897374 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68434159 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67777148 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67628885 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67600550 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67223489 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66224489 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.65901081 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65498751 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61713651 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60896398 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60001653 |
| 121 | Base excision repair_Homo sapiens_hsa03410 | 0.59815542 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59528850 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57825551 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57496606 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56966151 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55164371 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54947578 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53781225 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53477265 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52760456 |
| 131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51118993 |
| 132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51044710 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50558742 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49894587 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.49796517 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.49350994 |
| 137 | RNA polymerase_Homo sapiens_hsa03020 | 0.48381167 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48048972 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48043243 |
| 140 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44034226 |
| 141 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43494909 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43385791 |
| 143 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43333279 |
| 144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43194647 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43179808 |
| 146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42857259 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42181288 |
| 148 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41991598 |
| 149 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41175561 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41063906 |
| 151 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40788927 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.39443986 |
| 153 | Peroxisome_Homo sapiens_hsa04146 | 0.39384492 |
| 154 | Melanoma_Homo sapiens_hsa05218 | 0.39197437 |
| 155 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38157729 |
| 156 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37520736 |
| 157 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37070888 |
| 158 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35664487 |
| 159 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33975329 |
| 160 | Bile secretion_Homo sapiens_hsa04976 | 0.32676427 |
| 161 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32620419 |
| 162 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.31999884 |
| 163 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31795586 |
| 164 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31294233 |
| 165 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30558608 |
| 166 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29919019 |
| 167 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28860947 |
| 168 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28375881 |
| 169 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27874365 |
| 170 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27443620 |
| 171 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27264546 |
| 172 | Purine metabolism_Homo sapiens_hsa00230 | 0.26621846 |
| 173 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25973513 |
| 174 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23091149 |
| 175 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22669867 |
| 176 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21255723 |

